3 biotech winners for 2006 Peptech:target 2.25, 3 mos
Bta : target 3 after Glaxo trial
SRX : Sirtex target $3 short term, $6-7 medium term after large reveunue and profit expansion wnd widespread apllicability of Sir spheres to treat many different metastases to liver with many different chemotherapeutics already underway
- Forums
- ASX - General
- australias top management teams
australias top management teams, page-7
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online